Detection of human cytomegalovirus genome and gene products in central nervous system tumours
2005

Human Cytomegalovirus in Brain Tumors

Sample size: 132 publication Evidence: moderate

Author Information

Author(s): Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Trémoulet M, Delisle M B, Brousset P

Primary Institution: Purpan Hospital, Toulouse, France

Hypothesis

Is human cytomegalovirus (HCMV) implicated in the development of malignant gliomas?

Conclusion

The study suggests that HCMV is unlikely to be involved in the development of human malignant gliomas in the examined French cases.

Supporting Evidence

  • HCMV was detected in only a small number of glioblastoma cases.
  • No significant proportion of tumor cells contained HCMV genomes or proteins.
  • Previous studies suggested a link between HCMV and gliomas, but this study found no strong evidence.

Takeaway

Researchers looked for a virus called HCMV in brain tumors but found it was not a major cause of these tumors.

Methodology

The study used immunohistochemistry and in situ hybridization on tissue microarrays from CNS tumor samples.

Limitations

The study was limited by the small number of positive cases and the potential degradation of nucleic acids due to tissue processing.

Participant Demographics

Patients aged between 31 and 87 years with various CNS tumors.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602339

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication